<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
                      "http://www.w3.org/TR/REC-html40/loose.dtd">
<HTML>
<HEAD>
<TITLE>extropians: Re: CRYONICS: FM-2030's suspension</TITLE>
<META NAME="Author" CONTENT="zeb haradon (zebharadon@hotmail.com)">
<META NAME="Subject" CONTENT="Re: CRYONICS: FM-2030's suspension">
</HEAD>
<BODY BGCOLOR="#FFFFFF" TEXT="#000000">
<H1>Re: CRYONICS: FM-2030's suspension</H1>
<!-- received="Wed Jul 12 09:06:07 2000" -->
<!-- isoreceived="20000712150607" -->
<!-- sent="Wed, 12 Jul 2000 15:06:00 GMT" -->
<!-- isosent="20000712150600" -->
<!-- name="zeb haradon" -->
<!-- email="zebharadon@hotmail.com" -->
<!-- subject="Re: CRYONICS: FM-2030's suspension" -->
<!-- id="20000712150600.24745.qmail@hotmail.com" -->
<!-- inreplyto="CRYONICS: FM-2030's suspension" -->
<STRONG>From:</STRONG> zeb haradon (<A HREF="mailto:zebharadon@hotmail.com?Subject=Re:%20CRYONICS:%20FM-2030's%20suspension&In-Reply-To=&lt;20000712150600.24745.qmail@hotmail.com&gt;"><EM>zebharadon@hotmail.com</EM></A>)<BR>
<STRONG>Date:</STRONG> Wed Jul 12 2000 - 09:06:00 MDT
<P>
<!-- next="start" -->
<UL>
<LI><STRONG>Next message:</STRONG> <A HREF="0940.html">Michael S. Lorrey: "Re: Napster: thoughts and comments?"</A>
<LI><STRONG>Previous message:</STRONG> <A HREF="0938.html">Michael S. Lorrey: "Re: Napster: thoughts and comments?"</A>
<LI><STRONG>Maybe in reply to:</STRONG> <A HREF="0932.html">Brian D Williams: "CRYONICS: FM-2030's suspension"</A>
<!-- nextthread="start" -->
<LI><STRONG>Next in thread:</STRONG> <A HREF="1051.html">S.J. Van Sickle: "Re: CRYONICS: FM-2030's suspension"</A>
<!-- reply="end" -->
<LI><STRONG>Messages sorted by:</STRONG> 
<A HREF="date.html#939">[ date ]</A>
<A HREF="index.html#939">[ thread ]</A>
<A HREF="subject.html#939">[ subject ]</A>
<A HREF="author.html#939">[ author ]</A>
</UL>
<HR NOSHADE><P>
<!-- body="start" -->
<P>
Can anyone give a more detailed description of the new surgical techniques 
<BR>
being used? I am not familiar.
<BR>
<P><P><EM>&gt;From: Brian D Williams &lt;<A HREF="mailto:talon57@well.com?Subject=Re:%20CRYONICS:%20FM-2030's%20suspension&In-Reply-To=&lt;20000712150600.24745.qmail@hotmail.com&gt;">talon57@well.com</A>&gt;
</EM><BR>
<EM>&gt;Reply-To: <A HREF="mailto:extropians@extropy.com?Subject=Re:%20CRYONICS:%20FM-2030's%20suspension&In-Reply-To=&lt;20000712150600.24745.qmail@hotmail.com&gt;">extropians@extropy.com</A>
</EM><BR>
<EM>&gt;To: <A HREF="mailto:extropians@extropy.org?Subject=Re:%20CRYONICS:%20FM-2030's%20suspension&In-Reply-To=&lt;20000712150600.24745.qmail@hotmail.com&gt;">extropians@extropy.org</A>
</EM><BR>
<EM>&gt;Subject: CRYONICS: FM-2030's suspension
</EM><BR>
<EM>&gt;Date: Wed, 12 Jul 2000 07:26:10 -0700 (PDT)
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;This is good news, now not only is FM-2030 in the excellent hands
</EM><BR>
<EM>&gt;of the folks at Alcor, but apparently he was suspended using the
</EM><BR>
<EM>&gt;recent breakthrough in protocol. Very good news indeed.
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;                           The Visionary
</EM><BR>
<EM>&gt;                              FM-2030
</EM><BR>
<EM>&gt;                        Now time traveling
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;Date: Tue, 11 Jul 2000 13:56:14 -0600
</EM><BR>
<EM>&gt;From: Linda Chamberlain &lt;<A HREF="mailto:linda@alcor.org?Subject=Re:%20CRYONICS:%20FM-2030's%20suspension&In-Reply-To=&lt;20000712150600.24745.qmail@hotmail.com&gt;">linda@alcor.org</A>&gt;
</EM><BR>
<EM>&gt;Subject: FM-2030 placed into cryostasis
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;News Release:
</EM><BR>
<EM>&gt;For additional information contact
</EM><BR>
<EM>&gt;Linda Chamberlain, Executive Director
</EM><BR>
<EM>&gt;<A HREF="mailto:linda@alcor.org?Subject=Re:%20CRYONICS:%20FM-2030's%20suspension&In-Reply-To=&lt;20000712150600.24745.qmail@hotmail.com&gt;">linda@alcor.org</A>
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;WHY BE PART OF THE LAST GENERATION TO DIE BEFORE ANTI-AGING
</EM><BR>
<EM>&gt;MEDICINE SOLVES THE AGING PROBLEM?
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;FOR IMMEDIATE RELEASE
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;Scottsdale, AZ, 11 July 2000.    Futurist, lecturer and writer
</EM><BR>
<EM>&gt;FM-2030 was placed into cryostasis on July 10, 2000 at the Alcor
</EM><BR>
<EM>&gt;Life Extension Foundation in Scottsdale, Arizona.
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;FM-2030 was a strong advocate (for three decades) of using
</EM><BR>
<EM>&gt;cryostasis as a possible means for saving the lives of individuals
</EM><BR>
<EM>&gt;who cannot be saved by current medical technology.   His books
</EM><BR>
<EM>&gt;include The Upwingers, Optimum One, Telespheres, and Are You
</EM><BR>
<EM>&gt;Transhuman?.   He taught futurist classes over the
</EM><BR>
<EM>&gt;years at such locations as UCLA and the Smithsonian Institution,
</EM><BR>
<EM>&gt;and he wrote articles for major news papers like the New York Times
</EM><BR>
<EM>&gt;and the Los Angeles Times.
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;New surgical techniques being pioneered at Alcor were used for the
</EM><BR>
<EM>&gt;first time in the cryoprotection operation for FM-2030.  These
</EM><BR>
<EM>&gt;resulted in vastly improved cryoprotection for this long-time
</EM><BR>
<EM>&gt;supporter of the cryostasis process as a potentially life saving,
</EM><BR>
<EM>&gt;though still experimental, technique.
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;The Alcor Life Extension Foundation was founded in 1972 as a
</EM><BR>
<EM>&gt;non-profit, tax-exempt 501(c)(3) organization, and has 39 patients
</EM><BR>
<EM>&gt;in cryostasis.  Alcor is the world's largest provider of
</EM><BR>
<EM>&gt;professional cryotransport services with over 500 members who have
</EM><BR>
<EM>&gt;pre-arranged for cryotransport.  Alcor's Emergency CryoTransport
</EM><BR>
<EM>&gt;System (ECS) is a medical-style rescue network patterned after
</EM><BR>
<EM>&gt;Emergency Medical System (EMS).  Alcor CryoTransport Technicians,
</EM><BR>
<EM>&gt;as with EMS technicians, are remotely advised by on-call physicians
</EM><BR>
<EM>&gt;who are Alcor members and/or contract physicians.
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;If an individual is successfully placed into cryostasis, there are
</EM><BR>
<EM>&gt;patient funds for long term care.  These funds are maintained in an
</EM><BR>
<EM>&gt;independent Patient Care Trust and are invested such that they have
</EM><BR>
<EM>&gt;traditionally earned at least double the current costs of keeping
</EM><BR>
<EM>&gt;patients in cryostasis, providing extra safety margin against poor
</EM><BR>
<EM>&gt;investment years.
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;Can patients in cryostasis be successfully resuscitated, perhaps
</EM><BR>
<EM>&gt;decades from now, when new medical breakthroughs can reverse the
</EM><BR>
<EM>&gt;damage caused by diseases not currently curable?   The medical and
</EM><BR>
<EM>&gt;scientific foundations for this are discussed at length in a new
</EM><BR>
<EM>&gt;book: Nanomedicine, Volume I, by Robert Freitas. These
</EM><BR>
<EM>&gt;revolutionary concepts were presented by Ralph Merkle, PhD at the
</EM><BR>
<EM>&gt;Fourth Alcor Conference on Life Extension Technologies held in June
</EM><BR>
<EM>&gt;2000.
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;For more information on the Alcor Life Extension Foundation, see
</EM><BR>
<EM>&gt;our website at &lt;<A HREF="http://www.alcor.org/">http://www.alcor.org/</A>&gt;www.alcor.org
</EM><BR>
<EM>&gt;
</EM><BR>
<EM>&gt;###
</EM><BR>
<P><P>---------------------------------------------------
<BR>
Zeb Haradon (<A HREF="mailto:zebharadon@hotmail.com?Subject=Re:%20CRYONICS:%20FM-2030's%20suspension&In-Reply-To=&lt;20000712150600.24745.qmail@hotmail.com&gt;">zebharadon@hotmail.com</A>)
<BR>
My personal webpage:
<BR>
<A HREF="http://www.inconnect.com/~zharadon/ubunix">http://www.inconnect.com/~zharadon/ubunix</A>
<BR>
A movie I'm directing:
<BR>
<A HREF="http://www.elevatormovie.com">http://www.elevatormovie.com</A>
<BR>
<P>________________________________________________________________________
<BR>
Get Your Private, Free E-mail from MSN Hotmail at <A HREF="http://www.hotmail.com">http://www.hotmail.com</A>
<BR>
<P><!-- body="end" -->
<HR NOSHADE>
<UL>
<!-- next="start" -->
<LI><STRONG>Next message:</STRONG> <A HREF="0940.html">Michael S. Lorrey: "Re: Napster: thoughts and comments?"</A>
<LI><STRONG>Previous message:</STRONG> <A HREF="0938.html">Michael S. Lorrey: "Re: Napster: thoughts and comments?"</A>
<LI><STRONG>Maybe in reply to:</STRONG> <A HREF="0932.html">Brian D Williams: "CRYONICS: FM-2030's suspension"</A>
<!-- nextthread="start" -->
<LI><STRONG>Next in thread:</STRONG> <A HREF="1051.html">S.J. Van Sickle: "Re: CRYONICS: FM-2030's suspension"</A>
<!-- reply="end" -->
<LI><STRONG>Messages sorted by:</STRONG> 
<A HREF="date.html#939">[ date ]</A>
<A HREF="index.html#939">[ thread ]</A>
<A HREF="subject.html#939">[ subject ]</A>
<A HREF="author.html#939">[ author ]</A>
</UL>
<!-- trailer="footer" -->
<HR NOSHADE>
<P>
<SMALL>
<EM>
This archive was generated by <A HREF="http://www.hypermail.org/">hypermail 2b29</A> 
: <EM>Mon Oct 02 2000 - 17:34:25 MDT</EM>
</EM>
</SMALL>
</BODY>
</HTML>
